Preoperative triglyceride-glucose index and 30-day surgical site infection in OSCC patients without documented diabetes: a retrospective cohort study.
5 affiliations
- 1Department of Stomatology, Taikang Xianlin Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.
- 2Department of Stomatology, The Fourth Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
- 3Department of Thoracic Surgery, The Affiliated Huai'an No. 1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, China.
- 4Only You Dental Clinic, Nanjing, Jiangsu, China.
- 5Department of Stomatology, Taikang Xianlin Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China. [email protected].
Abstract
Background
Surgical site infection (SSI) remains an important complication after oral squamous cell carcinoma (OSCC) surgery. Although diabetes is a recognized infection risk factor, metabolic vulnerability in patients without documented diabetes is less understood. The triglyceride-glucose (TyG) index is a surrogate marker of insulin resistance, but its association with postoperative SSI in OSCC remains unclear.Methods
This retrospective cohort included 381 OSCC patients without documented diabetes who underwent curative-intent surgery between January 2017 and December 2024. The standard TyG index was calculated as ln [triglycerides (mg/dL) × fasting plasma glucose (mg/dL) / 2]. The primary outcome was 30-day SSI adjudicated according to CDC/NHSN criteria. Multivariable logistic regression used a primary surgical-adjusted model including demographic, lifestyle/comorbidity, tumor, nutritional, and surgical-complexity variables. Dose-response, sensitivity, discrimination, calibration, reclassification, and apparent decision curve analyses were evaluated.Results
Among 381 patients, 88 (23.1%) developed 30-day SSI. TyG was higher in patients with SSI than in those without SSI (8.77 ± 0.29 vs 8.59 ± 0.29, P < 0.001). In the primary surgical-adjusted model, each 0.1-unit increase in TyG was associated with higher SSI odds (adjusted odds ratio, 1.260; 95% confidence interval, 1.144-1.388; P < 0.001). The association remained directionally consistent after adjustment for HbA1c, exclusion of possible undiagnosed diabetes, restriction to TG/FPG measurements within 7 days before surgery, and extended perioperative adjustment. Restricted cubic splines showed a significant overall association without evidence of non-linearity. Adding TyG produced statistically significant but modest apparent discrimination gains in the clinical model (AUC, 0.634 to 0.712; ΔAUC, 0.078; P = 0.005) and surgical model (AUC, 0.682 to 0.737; ΔAUC, 0.054; P = 0.018), although optimism-corrected performance was attenuated. Decision curve analysis was exploratory.Conclusions
In OSCC patients without documented diabetes, higher preoperative TyG was associated with increased 30-day SSI risk and provided modest incremental predictive information. Given the internally derived design, limited events per predictor parameter, attenuation after optimism correction, and lack of external validation, these findings should be considered exploratory before clinical implementation.
Related
- Documented Surgical Site Infection After Cesarean Delivery at Kiziguro District Hospital, Rwanda: A Retrospective Record Review.
- Clinical Characteristics and Management of Pediatric Facial Wounds with Documented Infection or Delayed Presentation: A 25-Year Retrospective Case Series
- Epidural Abscess in Routine Preoperative MRI Reports Versus Documented Operative Findings, and Exploratory Mortality Risk Factors in Surgically Treated Spondylodiscitis: A Retrospective Single-Centre Study
- Oral Antibiotic Preparation Is Associated with Lower Surgical Site Infection After Ileostomy Closure: A Retrospective Cohort Study
- Associations of Preoperative and Early Postoperative Biomarkers with Wound Complications in a Clinically Restricted Surgical Population: A Retrospective Cohort Study
BibTeX
@article{su2026preoperative,
title = {{Preoperative triglyceride-glucose index and 30-day surgical site infection in OSCC patients without documented diabetes: a retrospective cohort study.}},
author = {Yongkuan Su and Yao Luo and Sujie Tang and Junjie Shi and Xiaodong Zhu and Jingchao Zhang and Bingyao Liu},
journal = {BMC oral health},
year = {2026},
month = aug,
doi = {10.1186/s12903-026-09500-2},
url = {https://europepmc.org/article/MED/42958172},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Preoperative triglyceride-glucose index and 30-day surgical site infection in OSCC patients without documented diabetes: a retrospective cohort study.
AU - Yongkuan Su
AU - Yao Luo
AU - Sujie Tang
AU - Junjie Shi
AU - Xiaodong Zhu
AU - Jingchao Zhang
AU - Bingyao Liu
PY - 2026
DA - 2026/08/04
JO - BMC oral health
DO - 10.1186/s12903-026-09500-2
UR - https://europepmc.org/article/MED/42958172
AB - Background Surgical site infection (SSI) remains an important complication after oral squamous cell carcinoma (OSCC) surgery. Although diabetes is a recognized infection risk factor, metabolic vulnerability in patients without documented diabetes is less understood. The triglyceride-glucose (TyG) index is a surrogate marker of insulin resistance, but its association with postoperative SSI in OSCC remains unclear.Methods This retrospective cohort included 381 OSCC patients without documented diabetes who underwent curative-intent surgery between January 2017 and December 2024. The standard TyG index was calculated as ln [triglycerides (mg/dL) × fasting plasma glucose (mg/dL) / 2]. The primary outcome was 30-day SSI adjudicated according to CDC/NHSN criteria. Multivariable logistic regression used a primary surgical-adjusted model including demographic, lifestyle/comorbidity, tumor, nutritional, and surgical-complexity variables. Dose-response, sensitivity, discrimination, calibration, reclassification, and apparent decision curve analyses were evaluated.Results Among 381 patients, 88 (23.1%) developed 30-day SSI. TyG was higher in patients with SSI than in those without SSI (8.77 ± 0.29 vs 8.59 ± 0.29, P < 0.001). In the primary surgical-adjusted model, each 0.1-unit increase in TyG was associated with higher SSI odds (adjusted odds ratio, 1.260; 95% confidence interval, 1.144-1.388; P < 0.001). The association remained directionally consistent after adjustment for HbA1c, exclusion of possible undiagnosed diabetes, restriction to TG/FPG measurements within 7 days before surgery, and extended perioperative adjustment. Restricted cubic splines showed a significant overall association without evidence of non-linearity. Adding TyG produced statistically significant but modest apparent discrimination gains in the clinical model (AUC, 0.634 to 0.712; ΔAUC, 0.078; P = 0.005) and surgical model (AUC, 0.682 to 0.737; ΔAUC, 0.054; P = 0.018), although optimism-corrected performance was attenuated. Decision curve analysis was exploratory.Conclusions In OSCC patients without documented diabetes, higher preoperative TyG was associated with increased 30-day SSI risk and provided modest incremental predictive information. Given the internally derived design, limited events per predictor parameter, attenuation after optimism correction, and lack of external validation, these findings should be considered exploratory before clinical implementation.
SN - 1472-6831
ER -